The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

17 articles for CM Thompson


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
p38MAP kinase inhibitors. Part 1: design and development of a new class of potent and highly selective inhibitors based on 3,4-dihydropyrido[3,2-d]pyrimidone scaffold.EBI
Merck Research Laboratories
Synthesis of fluorescent probes directed to the active site gorge of acetylcholinesterase.EBI
The University of Montana
Synthesis and biological activity of quinolinone and dihydroquinolinone p38 MAP kinase inhibitors.EBI
Merck Research Laboratories
Synthesis and in vitro pharmacology of substituted quinoline-2,4-dicarboxylic acids as inhibitors of vesicular glutamate transport.EBI
The University of Montana
Design and evaluation of a novel fluorescent CB2 ligand as probe for receptor visualization in immune cells.EBI
University of Montana
Conformationally-restricted amino acid analogues bearing a distal sulfonic acid show selective inhibition of system x(c)(-) over the vesicular glutamate transporter.EBI
The University of Montana
p38 MAP kinase inhibitors: metabolically stabilized piperidine-substituted quinolinones and naphthyridinones.EBI
Merck
Novel ketal ligands for the glucocorticoid receptor: in vitro and in vivo activity.EBI
Merck Research Laboratories
Novel heterocyclic glucocorticoids: in vitro profile and in vivo efficacy.EBI
Merck Research Laboratories
Hybrid-designed inhibitors of p38 MAP kinase utilizing N-arylpyridazinones.EBI
Merck Research Laboratories
Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase.EBI
Merck Research Laboratories
Quinoline-2,4-dicarboxylic acids: synthesis and evaluation as inhibitors of the glutamate vesicular transport system.EBI
The University of Montana
Synthesis and anti-acetylcholinesterase properties of novel β- and γ-substituted alkoxy organophosphonates.EBI
The University of Montana
Triazolo[4,5-D]pyrimidine derivativesBDB
Hoffmann-La Roche
Compounds and compositions as protein kinase inhibitorsBDB
Array Biopharma
Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereofBDB
Evotec
 
Synthesis and pharmacological evaluation of 4-[2- hydroxy-3-(4-phenyl-piperazin-1-yl)-propoxy]-4- azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dioneBDB
The Medical University of Warsaw